Previous close | 7.70 |
Open | 7.76 |
Bid | 7.92 x 200 |
Ask | 7.98 x 100 |
Day's range | 7.75 - 8.60 |
52-week range | 3.81 - 17.70 |
Volume | |
Avg. volume | 271,329 |
Market cap | 452.657M |
Beta (5Y monthly) | 0.25 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Over the last year, a good number of insiders have significantly increased their holdings in IGM Biosciences, Inc...
IGM Biosciences ( NASDAQ:IGMS ) Full Year 2023 Results Key Financial Results Net loss: US$246.4m (loss widened by 11...
IGM Biosciences, Inc. (IGMS) delivered earnings and revenue surprises of 4.72% and 31.47%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?